Hospital
Children's Hospital Los Angeles
Children's Hospital Los Angeles was paid $8.17M by Medicaid between Jan 2018 and Nov 2024, across 173 billing codes. Its largest line is 99221, — 16% of everything it billed.
33Billing provider infoCHILDREN'S HOSPITAL LOS ANGELES
LOS ANGELES, CA 90027
LOS ANGELES, CA 90027
33aNPI1003102781assigned 06/22/2011
33bProvider typeChildren's Hospital
28Total paid$8.17M
24GClaims260,828
24DCodes billed173
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Children's Hospital providers in California
Rank by total paid#5 of 17
Median peer was paid$1.44M
This provider vs. median5.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 39,922 | $599K | |
| 2019 | 32,595 | $992K | |
| 2020 | 29,208 | $981K | |
| 2021 | 33,515 | $1.25M | |
| 2022 | 42,628 | $1.96M | |
| 2023 | 45,665 | $1.65M | |
| 2024incomplete | 37,295 | $737K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99221 | 16% | 37,049 | 34,611 | $1.30M | |
| 0515 | 13% | 33,142 | 30,679 | $1.03M | |
| 0636 | 8.1% | 1,142 | 1,070 | $664K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 7.6% | 17,661 | 15,860 | $625K |
| 0450 | Emergency room services | 6.4% | 20,361 | 18,832 | $521K |
| 0123 | 6.1% | 247 | 232 | $502K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 4.1% | 371 | 371 | $336K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 3.6% | 622 | 615 | $295K |
| 0360 | 2.9% | 2,819 | 2,026 | $240K | |
| 97010 | 2.2% | 2,744 | 1,338 | $181K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.1% | 975 | 968 | $170K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.9% | 3,838 | 3,657 | $154K |
161 more codes
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.8% | 2,092 | $150K |
| 0761 | 1.6% | 3,187 | $131K | |
| 93325 | 1.6% | 1,113 | $128K | |
| 76770 | 1.3% | 1,364 | $104K | |
| Q3014 | Telehealth originating site facility fee | 1.1% | 3,996 | $88K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 1,202 | $86K |
| 93975 | 1.0% | 654 | $84K | |
| 95812 | <1% | 1,526 | $70K | |
| 97799 | <1% | 1,241 | $64K | |
| 0710 | <1% | 2,913 | $59K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,307 | $54K |
| 76827 | <1% | 421 | $52K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,615 | $49K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 203 | $44K |
| 80053 | Comprehensive metabolic panel | <1% | 4,399 | $39K |
| 97750 | <1% | 550 | $38K | |
| 97802 | <1% | 556 | $38K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,136 | $37K |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 6,146 | $37K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,751 | $35K |
| 94729 | <1% | 827 | $34K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,686 | $32K |
| 76825 | <1% | 422 | $31K | |
| 94726 | <1% | 827 | $31K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,937 | $29K |
| G0378 | Hospital observation service, per hour | <1% | 537 | $29K |
| 82728 | <1% | 1,721 | $23K | |
| J3490 | Unclassified drugs | <1% | 7,946 | $23K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,048 | $23K |
| A4649 | Surgical supply; miscellaneous | <1% | 14,822 | $22K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 811 | $21K |
| 97139 | <1% | 334 | $21K | |
| 92570 | <1% | 488 | $20K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 161 | $19K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 298 | $19K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 595 | $18K |
| 85027 | <1% | 2,652 | $15K | |
| 97116 | <1% | 1,694 | $15K | |
| 83550 | <1% | 1,625 | $14K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,429 | $12K |
| 97165 | <1% | 177 | $12K | |
| 84703 | <1% | 2,114 | $12K | |
| 97014 | <1% | 818 | $12K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 484 | $11K |
| J2704 | Injection, propofol, 10 mg | <1% | 2,135 | $11K |
| 92587 | <1% | 186 | $11K | |
| 94060 | <1% | 368 | $11K | |
| T1024 | Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter | <1% | 196 | $10K |
| 85045 | <1% | 2,343 | $9K | |
| 85007 | <1% | 2,400 | $8K | |
| 81003 | <1% | 5,045 | $8K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,919 | $8K |
| 99000 | <1% | 2,390 | $7K | |
| 86140 | <1% | 1,781 | $7K | |
| 86003 | <1% | 77 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 662 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 757 | $6K |
| 70310 | <1% | 400 | $6K | |
| 94010 | <1% | 352 | $6K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 40 | $6K |
| 87650 | <1% | 746 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 409 | $6K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 565 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 217 | $5K |
| 92555 | <1% | 262 | $5K | |
| 73090 | <1% | 256 | $5K | |
| 0760 | <1% | 74 | $4K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 88 | $4K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 194 | $4K |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 588 | $3K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 72 | $3K |
| 96156 | <1% | 37 | $3K | |
| 69210 | <1% | 680 | $3K | |
| 87631 | <1% | 63 | $3K | |
| 74019 | <1% | 322 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,076 | $3K |
| 82947 | <1% | 722 | $3K | |
| 90686 | <1% | 254 | $3K | |
| 73610 | <1% | 152 | $3K | |
| 93320 | <1% | 40 | $3K | |
| 87077 | <1% | 764 | $3K | |
| 99283 | Emergency room visit (moderate) | <1% | 69 | $3K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 19 | $3K |
| 85652 | <1% | 1,118 | $3K | |
| 97803 | <1% | 61 | $2K | |
| 92060 | <1% | 202 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 111 | $2K |
| 73590 | <1% | 86 | $2K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 91 | $2K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 252 | $2K |
| 90656 | <1% | 77 | $2K | |
| 76536 | <1% | 39 | $1K | |
| 72080 | <1% | 72 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 437 | $1K |
| 84439 | <1% | 139 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 287 | $1K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 33 | $1K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 89 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 506 | $930.37 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 39 | $920.15 |
| 83615 | <1% | 206 | $897.42 | |
| 92579 | <1% | 28 | $897.28 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 189 | $810.31 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 299 | $796.84 |
| 73080 | <1% | 74 | $767.93 | |
| 92550 | <1% | 12 | $744.16 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 338 | $742.13 |
| 82785 | <1% | 63 | $739.89 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 60 | $736.47 |
| 97755 | <1% | 97 | $696.88 | |
| 85730 | <1% | 136 | $684.97 | |
| 94760 | <1% | 112 | $682.75 | |
| 87186 | <1% | 164 | $677.25 | |
| 77074 | <1% | 18 | $654.88 | |
| 81015 | <1% | 339 | $608.46 | |
| 85610 | <1% | 165 | $567.11 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 12 | $563.80 |
| 97166 | <1% | 50 | $563.64 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 97 | $547.04 |
| 72170 | <1% | 28 | $461.33 | |
| 92582 | <1% | 13 | $445.68 | |
| 83690 | <1% | 147 | $445.67 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 167 | $398.57 |
| 88304 | <1% | 40 | $346.60 | |
| 73140 | <1% | 15 | $344.97 | |
| 84100 | <1% | 96 | $302.82 | |
| 0250 | <1% | 2,547 | $265.96 | |
| 73100 | <1% | 14 | $258.03 | |
| 92504 | <1% | 17 | $252.24 | |
| 0259 | <1% | 3,217 | $243.89 | |
| 92567 | <1% | 27 | $235.32 | |
| 70360 | <1% | 13 | $226.46 | |
| 80061 | Lipid panel | <1% | 30 | $214.67 |
| 73070 | <1% | 14 | $194.44 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 14 | $146.00 |
| 83735 | <1% | 47 | $123.83 | |
| 73630 | <1% | 12 | $118.56 | |
| 0301 | <1% | 109 | $116.32 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 262 | $109.95 |
| 0251 | <1% | 66 | $86.30 | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 12 | $82.50 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 25 | $61.44 |
| 85014 | <1% | 56 | $54.22 | |
| 0270 | <1% | 6,655 | $45.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 14 | $39.48 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 58 | $0.00 |
| 0306 | 0% | 301 | $0.00 | |
| 0370 | 0% | 296 | $0.00 | |
| 99070 | 0% | 83 | $0.00 | |
| 0305 | 0% | 76 | $0.00 | |
| 96040 | 0% | 216 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 36 | $0.00 |
| 0324 | 0% | 46 | $0.00 | |
| 0271 | 0% | 33 | $0.00 | |
| 0771 | 0% | 22 | $0.00 | |
| 0001A | 0% | 17 | $0.00 | |
| 0320 | 0% | 12 | $0.00 | |
| 0300 | 0% | 592 | $0.00 | |
| 0272 | 0% | 727 | $0.00 | |
| 99001 | 0% | 29 | $0.00 | |
| 0002A | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLIEBERENZ, MAX (SR.VP/CFO)
| Provider | Location | Paid |
|---|---|---|
| Childrens Hospital of Los Angeles | Los Angeles, CA | $136.95M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.